Prostatis Group’s First Trust Capital Strength ETF FTCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,912
Closed -$806K 132
2023
Q3
$806K Buy
10,912
+523
+5% +$39.6K 0.39% 52
2023
Q2
$780K Buy
+10,389
New +$761K 0.36% 60
2023
Q1
Sell
-11,175
Closed -$838K 105
2022
Q4
$838K Sell
11,175
-30,738
-73% -$2.27M 0.51% 47
2022
Q3
$2.78M Buy
+41,913
New +$3.01M 3.21% 9

Other funds holding FTCS

Prostatis Group's FTCS Position: Q4 2023 in Review

Prostatis Group sold out of First Trust Capital Strength ETF (FTCS) in Q4 2023, closing a stake of 10,912 shares — an estimated $806K sold.

Prostatis Group first reported a position in FTCS in Q3 2022 and held it in 4 quarters. The position peaked at $2.78M in Q3 2022. 463 funds tracked by Wall St. Rank hold FTCS as of Q4 2023.

  • Prostatis Group reported no remaining First Trust Capital Strength ETF position as of Q4 2023 after selling out during the quarter.
  • Prostatis Group sold 10,912 First Trust Capital Strength ETF shares in Q4 2023, an estimated $806K.
  • Prostatis Group first reported a position in First Trust Capital Strength ETF in Q3 2022 and held it in 4 quarters.
  • Prostatis Group's First Trust Capital Strength ETF position peaked at $2.78M in Q3 2022.
  • 463 funds tracked by Wall St. Rank held First Trust Capital Strength ETF as of Q4 2023.

Based on Prostatis Group's 13F filing for Q4 2023, filed 21 Mar 2025.